Overall rank by patents
#21,933
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,).
The verdict
According to USPTO PatentsView, Trans ranks #21,933 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R21933 · US Corporation #21,933 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: TPK Touch Systems (xiamen) Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Trans Union · this assignee
33 score
3D Lighting Innovati… · lowest
7 score
What this shows Trans's Innovation Score is 33.0/100 (top 57% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Trans Union Llc is a focused PatentsView assignee: 4 CPC subclasses with 69.2% of grants classified under G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2016. By volume, Trans sits between TPK Touch Systems (xiamen) Inc. and Tricol Biomedical, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
TPK Touch Systems (Xiamen) Inc.
13 patents
TPR INDUSTRY CO., LTD.
13 patents
TRACTABLE LIMITED
13 patents
TRAININGMASK L.L.C
13 patents
TRC Services, Inc.
13 patents
TRI-GREAT INTERNATIONAL LTD.
13 patents
TRIAD SPORTS GROUP, LLC
13 patents
TRICOL BIOMEDICAL, INC.
13 patents
TRANS UNION LLC
13 patents
What this shows Trans holds 13 patents at rank #21,899, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #21,899 in granted patent volume.
Other assignees with the most granted patents in Trans's primary technology class.
Trans's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 Top 57% higher than 43% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 7.7% |
| 2017 | 1 | 7.7% |
| 2018 | 1 | 7.7% |
| 2019 | 2 | 15.4% |
| 2020 | 1 | 7.7% |
| 2021 | 2 | 15.4% |
| 2022 | 2 | 15.4% |
| 2023 | 1 | 7.7% |
| 2024 | 1 | 7.7% |
| 2025partial year | 1 | 7.7% |
Top 4 of 4 technology areas
Overall rank by patents
#21,933
of 50,000 tracked assignees
33.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.